Lenka Jakubíková
YOU?
Author Swipe
View article: The lung cancer patient quality of life during the first line of treatment – multicenter prospective data
The lung cancer patient quality of life during the first line of treatment – multicenter prospective data Open
View article: Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis Open
Our case report emphasizes the need for a broader differential diagnosis in the event of pulmonary complications during the administration of immunotherapy. Correct diagnosis of these complications can, among other things, fundamentally af…
View article: Lung Cancer in the Czech Republic
Lung Cancer in the Czech Republic Open
View article: Table of Contents
Table of Contents Open
View article: Direct and indirect impacts of the COVID-19 pandemic on patients with pulmonary and pleural malignancies – a retrospective analysis of patient outcomes treated at Department of Respiratory Diseases, University Hospital Brno, during the 2nd and 3rd coronavirus waves
Direct and indirect impacts of the COVID-19 pandemic on patients with pulmonary and pleural malignancies – a retrospective analysis of patient outcomes treated at Department of Respiratory Diseases, University Hospital Brno, during the 2nd and 3rd coronavirus waves Open
Patients with lung and pleural malignancies have a high risk of severe course of SARS-CoV-2 infection and mortality. Moreover, the ongoing SARS-CoV-2 infection as well as postcovid changes can complicate the anticancer treatment itself.
View article: Atypical course of typical lung carcinoid
Atypical course of typical lung carcinoid Open
Carcinoids have been classified according to their embryonic origin in the past and are now categorized and classified as neuroendocrine tumors, including low malignant typical carcinoids, moderate malignant atypical carcinoids, and highly…
View article: Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience
Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience Open
Background Management of non-small-cell lung cancer (NSCLC) is affected by regional specificities. The present study aimed at determining diagnostic and therapeutic procedures including outcome of patients with NSCLC stage III in the real-…
View article: Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer Open
The results of the present retrospective exploratory analysis underscore the importance of knowing the exact type of concomitant medication, the route of administration, the dose of medication, and the region of the ongoing study. The pres…
View article: Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer Open
Tumor histology was the only clinical parameter predicting the outcome of nivolumab treatment. Among the laboratory parameters, our analysis identified a laboratory panel reflecting chronic inflammation as a potential predictive marker of …
View article: Treatment of patients with non-small cell cancer and EGFR mutations
Treatment of patients with non-small cell cancer and EGFR mutations Open
Klinika nemocí plicních a tuberkulózy LF Masarykovy univerzity a Fakultní nemocnice Brno 2 Interní hematologická a onkologická klinika, Centrum molekulární biologie a genové terapie